UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549



FORM 10-QSB/A

AMENDMENT NO. 1



[X]

Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934



For the quarterly period ended JUNE 30, 2004



[__]

Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934



For the transition period to





Commission File Number

000-49833



ACRONGENOMICS INC.



(Exact name of small Business Issuer as specified in its charter)



NEVADA

52-2219285

(State or other jurisdiction of

(IRS Employer Identification No.)

incorporation or organization)





1530 9th Avenue, S.E.

Calgary, Alberta, Canada

T2G 0T7



(Address of principal executive offices)

(Zip Code)



Issuer=s telephone number, including area code:

(403) 693-8014



N/A

(Former name, former address and former fiscal year, if changed since last report)



Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the issuer was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days

[X] Yes    [__] No



State the number of shares outstanding of each of the issuers classes of common stock, as of the latest practicable date:  14,977,000 Shares of $0.001 par value Common Stock outstanding as of August 6, 2004.





Transitional Small Business Disclosure Format (check one): Yes  [   ]   No  [ X ]











This Amendment No. 1 to Form 10-QSB for the period ended June 30, 2004 has been prepared and filed solely for the purpose of correcting a typographical error found in the Registrants Consolidated Statement of Cash Flow for the six (6) months ended June 30, 2004.  Therefore, onlysuch corrected Consolidated Statement of Cash Flow is set forth in this Amendment No.1.







2









|                                                   
|---------------------------------------------------
|ACRONGENOMICS, INC.                                
|(Formerly Cellway Ventures Inc.)                   
|(A Development Stage Company)                      
|CONSOLIDATED                                       
|STATEMENT OF CASH FLOW                             
|(Unaudited)                                        
|FOR THE SIX (6) MONTHS ENDED JUNE 30, 2004 AND 2003
|(Stated in U.S. Dollars)                           
|                                                   
|                                                   
|                                                   
|                                                   
|                                                   
|                                                   
|CASH FLOW FROM OPERATING ACTIVITIES                
|Net Loss for the Period                            
|Amortization                                       
|                                                   
|ADJUSTMENTS TO RECONCILE NET LOSS                  
|TO CASH USED BY OPERATING ACTIVITIES               
|Change in Accounts & Trusts Receivable             
|Change in Accounts Payable                         
|Change in Prepaid Expenses                         
|Change in Deposits                                 
|                                                   
|                                                   
|                                                   
|CASH FLOW FROM INVESTING ACTIVITIES                
|Purchase of Capital Assets                         
|                                                   
|CASH FLOW FROM FINANCING ACTIVITIES                
|Share Capital                                      
|Advances from Shareholder                          
|                                                   
|                                                   
|                                                   
|                                                   
|                                                   
|INCREASE (DECREASE) IN CASH                        
|                                                   
|CASH,Beginning of Period                           
|                                                   
|CASH, End of Period                                
|                                                   
|                                                   
|                                                   



3



SIGNATURES



In accordance with the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this amended report to be signed on its behalf by the undersigned, thereunto duly authorized.



ACRONGENOMICS, INC.



Date: August 19, 2004





By:/s/ Ron Lizee

Name:

Ron Lizee

Title:

Chief Financial Officer



4